Entyvio and Bacillus infection - a phase IV clinical study of FDA data

Summary:

Bacillus infection is reported as a side effect among people who take Entyvio (vedolizumab), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Tofacitinib, and have Ulcerative colitis.

The phase IV clinical study analyzes which people have Bacillus infection when taking Entyvio. It is created by eHealthMe based on reports of 23,685 people who have side effects when taking Entyvio from the FDA, and is updated regularly.

What is Entyvio?

Entyvio has active ingredients of vedolizumab. It is often used in crohn's disease. eHealthMe is studying from 23,827 Entyvio users. Check the latest studies of Entyvio.

What is Bacillus infection?

Bacillus infection is found to be associated with 103 drugs and 380 conditions by eHealthMe. Check the latest studies of Bacillus infection.

On Jul, 03, 2026

23,685 people reported to have side effects when taking Entyvio.
Among them, 35 people (0.15%) have Bacillus infection.

Among these 35 people:

How long have people been on Entyvio when they have Bacillus infection? *

What is the gender of people who have Bacillus infection when taking Entyvio? *

female: 100 %
male: 0.0 %

What is the age of people who have Bacillus infection when taking Entyvio? *

What are other drugs people take besides Entyvio? *

Tofacitinib: 30 people, 85.71%
Mesalamine: 29 people, 82.86%
Desoximetasone: 29 people, 82.86%
Prednisolone: 29 people, 82.86%
Mercaptopurine: 29 people, 82.86%
Raltegravir: 28 people, 80.00%
Methylprednisolone: 27 people, 77.14%
Betamethasone Dipropionate: 24 people, 68.57%
Prednisone: 23 people, 65.71%
Truvada: 22 people, 62.86%

What are other side effects people have besides Bacillus infection? *

Weight Increased: 34 people, 97.14%
Furuncle (infection of the hair follicle): 34 people, 97.14%
Drug Ineffective: 34 people, 97.14%
Cushingoid (obesity and weakening of the muscles): 34 people, 97.14%
Central Obesity (belly fat): 34 people, 97.14%
Cellulitis (infection under the skin): 34 people, 97.14%
Escherichia Infection (bacterial infection by escherichia coli): 33 people, 94.29%
Cataract (clouding of the lens inside the eye): 33 people, 94.29%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 32 people, 91.43%
Cushing's Syndrome (obesity, a rounded face, increased fat): 3 people, 8.57%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 35 people, 100.00%
Hiv Infection: 34 people, 97.14%

* Approximation only. Some reports may have incomplete information.

Do you take Entyvio and have Bacillus infection?

- Check whether Bacillus infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Entyvio:

Entyvio (23,827 reports)

Browse all side effects of Entyvio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bacillus infection:

Bacillus infection (103 drugs)

Browse all the conditions that are associated with Bacillus infection:

Bacillus infection (380 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vedolizumab (the active ingredients of Entyvio) and Entyvio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.